Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MultiHance vs Magnevist for Peripheral Arteries MRA
NCT00408083Phase 3Completed
- Sponsor
- Bracco Diagnostics Inc.
- Start
- Dec 2006
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gadobenate dimeglumine in Peripheral Arterial Disease (PAD), sponsored by Bracco Diagnostics Inc.. Started Dec 2006; status: completed.
02
Drugs
gadobenate dimeglumine
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT00408083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408083.